Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "Rheumatoid arthritis"

The ACR Research and Education Foundation Strengthens Its Mission With New Name, Tagline

Kimberly Retzlaff  |  November 1, 2012

 The American College of Rheumatology’s Research and Education Foundation (REF) has renamed itself “The Rheumatology Research Foundation: Advancing treatment, Finding cures,” as part of an overall branding strategy for the ever-growing fundraising branch of the ACR that better defines its mission and goals

Coding Corner Question: November

Staff  |  November 1, 2012

Test your knowledge of the level of medical decision making (MDM) for an evaluation and management (E/M) office visit of a patient whose rheumatoid arthritis is worse on chronic medicine, whose osteoporosis is stable on chronic medicine, and who presents with a new problem of elevated blood pressure (BP)

As Population Ages, Rheumatologists Prepare to Treat Elderly Patients with More Comorbidities

Vanessa Caceres  |  November 1, 2012

Cardiovascular disease, diabetes are among the conditions that add another layer of complexity in treating older rheumatology patients

Rheumatology Drug Updates: Apremilast, Golimumab, and More

Michele B. Kaufman, PharmD, BCGP  |  November 1, 2012

Information on new approvals and medication safety rheumatologists need to know

The Future is Here: The Role of Nurse Practitioners in Rheumatology

Ann Kepler  |  November 1, 2012

Nurse practitioners’ specialized knowledge and skills help to create an interlocking network of rheumatology patients and medical professionals

Rheumatologists Seek Public Vote for Research Grant Award

Michael O’Neal  |  October 17, 2012

Brigham and Women’s docs compete for BRIght Futures Prize for personalized medicine research

How the Mayo Clinic Maximizes Learning Opportunities Through Social Media

Carol Patton  |  October 17, 2012

The Mayo Clinic’s Center for Social Media has become a social media resource for healthcare providers nationwide

Treat to Target: Rheumatoid Arthritis in Pregnant Patients

Eliza F. Chakravarty, MD, MS  |  October 1, 2012

A treat-to-target approach to managing rheumatoid arthritis can work even in pregnant women

Nomenclature, Semantics, Jargon, Lingo, Eponyms, Etymology, and Terminology in Rheumatology

Prakash Pispati  |  October 1, 2012

Why rheumatologists must coin simple, comprehensible terms for what we read, speak and write to our patients

EULAR: Identify Arthritis Early, Treat it Effectively

Thomas R. Collins  |  October 1, 2012

Recent studies are uncovering genetic and environmental factors at play in the earliest stages of rheumatoid arthritis and medications that are effective in treating juvenile idiopathic arthritis

  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 45
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences